tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CATX Stock Latest News

Perspective Therapeutics price target raised to $8 from $7 at UBS
The FlyPerspective Therapeutics price target raised to $8 from $7 at UBS
2d ago
CATX
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
PremiumThe Fly
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
3d ago
CATX
Perspective Therapeutics price target raised to $8 from $7 at UBS
PremiumThe Fly
Perspective Therapeutics price target raised to $8 from $7 at UBS
3d ago
CATX
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
PremiumCompany Announcements
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress
5d ago
8K
CATX
Perspective Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Perspective Therapeutics initiated with an Overweight at Piper Sandler
1M ago
CATX
Buy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside
PremiumRatingsBuy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside
1M ago
CATX
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline
Premium
Company Announcements
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline
2M ago
8K
CATX
Midday Fly By: Disney slips despite Q1 beat, Devon to combine with Coterra
Premium
The Fly
Midday Fly By: Disney slips despite Q1 beat, Devon to combine with Coterra
2M ago
F
BAM
Perspective Therapeutics prices 39.58M shares at $3.79 in underwritten offering
PremiumThe Fly
Perspective Therapeutics prices 39.58M shares at $3.79 in underwritten offering
2M ago
CATX
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
2M ago
8K
CATX
Perspective Therapeutics price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
Perspective Therapeutics price target raised to $12 from $10 at H.C. Wainwright
2M ago
CATX
Perspective Therapeutics Highlights Progress in Radioligand Oncology Pipeline
PremiumCompany Announcements
Perspective Therapeutics Highlights Progress in Radioligand Oncology Pipeline
2M ago
8K
CATX
Undervalued Radiopharma Pipeline and Manufacturing Platform Underpin Buy Rating and $18 Target
PremiumRatingsUndervalued Radiopharma Pipeline and Manufacturing Platform Underpin Buy Rating and $18 Target
2M ago
CATX
Perspective Therapeutics outlines 2026 clinical and manufacturing priorities
Premium
Company Announcements
Perspective Therapeutics outlines 2026 clinical and manufacturing priorities
2M ago
8K
CATX
Perspective Therapeutics provides business updates, strategic priorities
Premium
The Fly
Perspective Therapeutics provides business updates, strategic priorities
2M ago
CATX
Perspective Therapeutics Reports Positive Interim Neuroendocrine Tumor Data
PremiumCompany Announcements
Perspective Therapeutics Reports Positive Interim Neuroendocrine Tumor Data
2M ago
8K
CATX
Perspective presents interim results from Phase 1/2 trial of 212PbVMT-a-NET
PremiumThe Fly
Perspective presents interim results from Phase 1/2 trial of 212PbVMT-a-NET
2M ago
CATX
Perspective Therapeutics Updates Corporate Presentation on Advancements
PremiumCompany Announcements
Perspective Therapeutics Updates Corporate Presentation on Advancements
4M ago
8K
CATX
Perspective Therapeutics assumed with a Buy at Truist
PremiumThe Fly
Perspective Therapeutics assumed with a Buy at Truist
4M ago
CATX
Perspective Therapeutics price target lowered to $7 from $18 at UBS
PremiumThe FlyPerspective Therapeutics price target lowered to $7 from $18 at UBS
4M ago
CATX
Buy Rating Affirmed for Perspective Therapeutics Amid Promising Developments in VMT-α-NET Program
Premium
Ratings
Buy Rating Affirmed for Perspective Therapeutics Amid Promising Developments in VMT-α-NET Program
4M ago
CATX
Perspective Therapeutics price target lowered to $7 from $18 at UBS
Premium
The Fly
Perspective Therapeutics price target lowered to $7 from $18 at UBS
4M ago
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >